A 10-year-old male with Down syndrome undergoes chemotherapy for cancer. Following treatment, he is most susceptible to:
A) acute lymphoblastic leukemia.
B) acute myelogenous leukemia.
C) non-Hodgkin lymphoma.
D) Hodgkin lymphoma.

Question

Quizplus · Accepted Answer

Individuals with Down syndrome have an increased risk for developing leukemia, particularly acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML). However, after chemotherapy, they are most susceptible to developing AML.

A 10-Year-Old Male with Down Syndrome Undergoes Chemotherapy for Cancer